Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Schizophrenia

Free Subscription 19.12.2011 2 Am J Med Genet B Neuropsychiatr Genet 1 Am J Psychiatry 1 Arch Gen Psychiatry 2 Biol Psychiatry 4 Br J Psychiatry 2 J Abnorm Psychol 1 J Clin Psychiatry 1 Nat Genet 3 Neuropsychopharmacology 1 Neurosci Lett 3 Pharmacopsychiatry 3 Psychol Med 6 Schizophr Res 1 Trends Neurosci

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Med Genet B Neuropsychiatr Genet

1. GOLDENBERG PC , Calkins ME, Richard J, McDonald-McGinn D, et al
   Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and At-Risk for psychosis.
   Am J Med Genet B Neuropsychiatr Genet. 2011 Dec 13. doi: 10.1002/ajmg.b.32005.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. SUN Y , Zhang J, Yuan Y, Yu X, et al
   Study of a possible role of the monoamine oxidase A (MAOA) gene in paranoid schizophrenia among a Chinese population.
   Am J Med Genet B Neuropsychiatr Genet. 2011 Dec 7. doi: 10.1002/ajmg.b.32009.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Am J Psychiatry

3. BAANDRUP L
   How dosing might influence the conclusion in an antipsychotic polypharmacy effectiveness trial.
   Am J Psychiatry. 2011;168:1117.
   PubMed     Text format     Related articles   
   
   
   

   
   Arch Gen Psychiatry

4. NORDENTOFT M , Mortensen PB, Pedersen CB
   Absolute risk of suicide after first hospital contact in mental disorder.
   Arch Gen Psychiatry. 2011;68:1058-64.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Biol Psychiatry

5. GREEN MF , Lee J
   Neural bases of emotional experience versus perception in schizophrenia.
   Biol Psychiatry. 2012;71:96-7.
   PubMed     Text format     Related articles   
   
   
   
6. BELGER A , Yucel GH, Donkers FC
   In Search of Psychosis Biomarkers in High-risk Populations: Is the Mismatch Negativity the One We've Been Waiting for?
   Biol Psychiatry. 2012;71:94-5.
   PubMed     Text format     Related articles   
   
   
   

   
   Br J Psychiatry

7. SHEPHERD AR
   The benefits of an active control arm.
   Br J Psychiatry. 2011;198:327.
   PubMed     Text format     Related articles   
   
   
   
8. KUMAR V
   Don Quixote and Sancho Panza: folie a deux?
   Br J Psychiatry. 2011;198:326-7.
   PubMed     Text format     Related articles   
   
   
   
9. HAMSHERE ML , O'Donovan MC, Jones IR, Jones L, et al
   Polygenic dissection of the bipolar phenotype.
   Br J Psychiatry. 2011;198:284-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. FAROOQ S , Taylor M
    Clozapine: dangerous orphan or neglected friend?
    Br J Psychiatry. 2011;198:247-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Abnorm Psychol

11. COHEN AS , Callaway DA, Najolia GM, Larsen JT, et al
    On "risk" and reward: Investigating state anhedonia in psychometrically defined schizotypy and schizophrenia.
    J Abnorm Psychol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MICOULAUD-FRANCHI JA , Aramaki M, Merer A, Cermolacce M, et al
    Toward an exploration of feeling of strangeness in schizophrenia: Perspectives on acousmatic and everyday listening.
    J Abnorm Psychol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Clin Psychiatry

13. KRAKOWSKI MI , Czobor P
    Executive function predicts response to antiaggression treatment in schizophrenia: a randomized controlled trial.
    J Clin Psychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Nat Genet

14. SKLAR P , Ripke S, Scott LJ, Andreassen OA, et al
    Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.
    Nat Genet. 2011;43:977-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Neuropsychopharmacology

15. BRUNZELL DH , McIntosh JM
    Alpha7 Nicotinic Acetylcholine Receptors Modulate Motivation to Self-Administer Nicotine: Implications for Smoking and Schizophrenia.
    Neuropsychopharmacology. 2011 Dec 14. doi: 10.1038/npp.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. SWERDLOW NR
    Beyond Antipsychotics: Pharmacologically-Augmented Cognitive Therapies (PACTs) for Schizophrenia.
    Neuropsychopharmacology. 2012;37:310-1.
    PubMed     Text format     Related articles   
    
    
    
17. FEIFEL D
    Oxytocin as a potential therapeutic target for schizophrenia and other neuropsychiatric conditions.
    Neuropsychopharmacology. 2012;37:304-5.
    PubMed     Text format     Related articles   
    
    
    

    
    Neurosci Lett

18. UTSUNOMIYA K , Shinkai T, Sakata S, Yamada K, et al
    Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: A reevaluation in East Asian populations.
    Neurosci Lett. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Pharmacopsychiatry

19. FRASCH K , Weiser P, Becker T, Langle G, et al
    Psychotropic Drug Treatment, Clinical Characteristics and Cognitive Processing Speed in Patients with Schizophrenia: Results from the ELAN Study.
    Pharmacopsychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. SHINFUKU M , Uchida H, Tsutsumi C, Suzuki T, et al
    How Psychotropic Polypharmacy in Schizophrenia Begins: A Longitudinal Perspective.
    Pharmacopsychiatry. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. RAPOSO NR , Ferreira AS, Gattaz WF
    Body mass index increase, serum leptin, adiponectin, neuropeptide Y and lipid levels during treatment with olanzapine and haloperidol.
    Pharmacopsychiatry. 2011;44:169-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Psychol Med

22. DUTTA R , Murray RM, Allardyce J, Jones PB, et al
    Mortality in first-contact psychosis patients in the UK: a cohort study.
    Psychol Med. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. SMEERDIJK M , Keet R, Dekker N, van Raaij B, et al
    Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial.
    Psychol Med. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. HORAN WP , Foti D, Hajcak G, Wynn JK, et al
    Impaired neural response to internal but not external feedback in schizophrenia.
    Psychol Med. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Schizophr Res

25. JAVITT DC , Buchanan RW, Keefe RS, Kern R, et al
    Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia.
    Schizophr Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. FUSAR-POLI P , Borgwardt S
    Predictive power of attenuated psychosis syndrome: Is it really low? The case of mild cognitive impairment.
    Schizophr Res. 2011.
    PubMed     Text format     Related articles   
    
    
    
27. HECHT EM , Landy DC
    Alpha-2 receptor antagonist add-on therapy in the treatment of schizophrenia; a meta-analysis.
    Schizophr Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. SPIEKER EA , Astur RS, West JT, Griego JA, et al
    Spatial memory deficits in a virtual reality eight-arm radial maze in schizophrenia.
    Schizophr Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. TAKEUCHI H , Suzuki T, Uchida H, Watanabe K, et al
    Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms.
    Schizophr Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. TSUTSUMI C , Uchida H, Suzuki T, Watanabe K, et al
    The evolution of antipsychotic switch and polypharmacy in natural practice--a longitudinal perspective.
    Schizophr Res. 2011;130.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Trends Neurosci

31. LEWIS DA , Curley AA, Glausier JR, Volk DW, et al
    Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.
    Trends Neurosci. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: